Health
Second-generation double antibody protects from SARS-CoV-2 and its tested variants – News-Medical.Net
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation…
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation ‘double antibody’ that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy.
Antibody-based immunotherapy was already shown to be effective against COVID-19 but faces two main obstacles: it needs to work against the circulating viral variants;…
-
Noosa News23 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Business24 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout
-
Noosa News23 hours agoSXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference